FDA applicant
3-D Matrix Europe SAS
FDA records 4 decisions for 3-D Matrix Europe SAS (Caluire Et Cuire, FR) from 2024 to 2026: 4 510(k) clearances. Most are in product codes QAU (Hemostatic Device For Endoscopic…) and PHN (Protective Coating, Mucoadhesive Application…). Its devices cite 4 predicates, 2 of them its own earlier devices. No recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided 3-D Matrix Europe SAS’s devices, and how often a recall has named them.
FDA decisions per year
1in 2025
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2024.
Planning a device like 3-D Matrix Europe SAS’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report